Minerva Neurosciences, Inc. (NERV)

2.32 +0.08 (+3.57%) USD  |  NASDAQ  |  Oct 30, 16:00
2.30 -0.02 (-0.86%) Pre-Market: 20:00
More

Minerva Neurosciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
August 10, 2026 --
August 07, 2026 --
May 18, 2026 --
May 11, 2026 --
May 05, 2026 --
April 15, 2026 --
Date Value
March 12, 2026 --
December 01, 2025 --
November 06, 2025 --
February 26, 2025 --
November 06, 2024 --
August 07, 2024 --
May 02, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Heron Therapeutics, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Corbus Pharmaceuticals Holdings, Inc. Upgrade
Ocugen, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade